We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Could DMT-Assisted Therapy Help Treat Mental Health Disorders?
Industry Insight

The role that psychedelic therapeutics could play in tackling many intractable mental health conditions has finally been recognized by mainstream medicine. To find out more, we spoke to Carol Routledge, Chief Medical & Scientific Officer at Small Pharma.

Read More

Smart Labs: The New Wave Transforming Laboratories Globally
Industry Insight

Emerging technologies have the potential to significantly transform the laboratory environment. In this Insight, Labforward's Phoebe Chubb outlines what the lab of the future will look like.

Read More

Exploring Genetic Variation and COVID-19 Clinical Variability
Industry Insight

One of the biggest challenges that scientists and healthcare professionals are facing during the COVID-19 pandemic is the high rate of clinical variability. Whilst some patients present as asymptomatic, others are developing more severe symptoms such as pneumonia, and some cases are ultimately proving fatal. Why? We speak with Dr Salvatore Viscomi to learn more.

Read More

Ensuring Data Integrity Compliance in Pharma With CDS Software
Industry Insight

Data integrity is fundamental to drug development and manufacturing but can be difficult to achieve for drug developers and manufacturers who have to navigate strict data integrity guidelines provided by regulatory authorities and find effective ways to attain compliance.

Read More

The Future of Sustainable HPC
Industry Insight

It is an unavoidable fact that high-performance computing (HPC) is an energy-intensive environment. In this Insight, OCF's Mischa van Kesteren investigates the steps we can take to address this and achieve a more sustainable future for HPC.

Read More

Cell and Gene Therapy Manufacturing: Achieving Consistency and Reducing Variability
Industry Insight

Cell and gene therapies first gained regulatory approval in 2017 by the US Food and Drug Administration (FDA). Several more therapies have since been developed, and there are now 18 approved to treat a variety of diseases Technology Networks recently had the pleasure of speaking with experts at Bio-Techne to learn more about the cell and gene therapy manufacturing process.

Read More

Make Data Work for You in the Race To Manufacture Effective Vaccines
Industry Insight

It’s imperative that scientists and leaders in the COVID-19 vaccine development space have good data management practices to ensure the quality of data and to recue the time-to-market now, and in the future. In this article, we explore how to make data work for you when manufacturing an effective vaccine.

Read More

Addressing Key Challenges in Cell and Gene Therapy Manufacturing
Industry Insight

Technology Networks spoke with Hugh H. Tansey, senior director of innovation and growth programs for laboratory equipment at Thermo Fisher Scientific to learn more about how the CTS Series Laboratory Equipment can deliver solutions for the key challenges in cell and gene therapy manufacturing.

Read More

Leading the Charge in the Cryo-EM Resolution Revolution
Industry Insight

See how cryo-EM advances are changing scientific research, particularly in cell and drug discovery studies, and the role that precision instruments are playing in this.

Read More

Accelerated Screen Identifies 25 Existing Drugs Capable of Disrupting SARS-CoV-2 Cell Entry
Industry Insight

A team from the National Center for Advancing Translational Sciences (NCATS) has screened existing drug compounds that have already passed through the entire drug development pipeline, to determine if any can disrupt the interaction between the SARS-CoV-2 spike protein and the host’s angiotensin converting enzyme 2 (ACE2) receptor.

Read More

 
Advertisement